A.R.T. Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-17,291
Closed -$1.17M 1345
2019
Q3
$1.17M Buy
17,291
+9,800
+131% +$660K 0.06% 488
2019
Q2
$642K Sell
7,491
-10,700
-59% -$917K 0.04% 640
2019
Q1
$1.62M Buy
18,191
+11,164
+159% +$992K 0.1% 316
2018
Q4
$598K Buy
+7,027
New +$598K 0.04% 640
2018
Q2
Sell
-33,127
Closed -$2.69M 1431
2018
Q1
$2.69M Sell
33,127
-1,100
-3% -$89.2K 0.11% 273
2017
Q4
$3.05M Buy
34,227
+21,700
+173% +$1.93M 0.14% 218
2017
Q3
$1.17M Sell
12,527
-40,473
-76% -$3.76M 0.06% 469
2017
Q2
$4.81M Buy
53,000
+19,400
+58% +$1.76M 0.26% 70
2017
Q1
$2.95M Buy
33,600
+10,600
+46% +$930K 0.14% 201
2016
Q4
$1.91M Buy
+23,000
New +$1.91M 0.11% 280
2016
Q2
Sell
-8,670
Closed -$715K 1368
2016
Q1
$715K Sell
8,670
-23,200
-73% -$1.91M 0.03% 719
2015
Q4
$3.34M Sell
31,870
-32,496
-50% -$3.4M 0.16% 158
2015
Q3
$6.78M Buy
64,366
+55,264
+607% +$5.82M 0.25% 90
2015
Q2
$1.24M Buy
+9,102
New +$1.24M 0.04% 640
2015
Q1
Sell
-63,952
Closed -$5.78M 1435
2014
Q4
$5.78M Buy
+63,952
New +$5.78M 0.22% 102
2014
Q3
Sell
-109,287
Closed -$6.8M 1315
2014
Q2
$6.8M Buy
109,287
+102,879
+1,605% +$6.4M 0.35% 45
2014
Q1
$437K Sell
6,408
-102,483
-94% -$6.99M 0.02% 810
2013
Q4
$7.66M Buy
108,891
+50,800
+87% +$3.57M 0.41% 32
2013
Q3
$4.19M Sell
58,091
-17,556
-23% -$1.27M 0.23% 104
2013
Q2
$4.22M Buy
+75,647
New +$4.22M 0.14% 207